Nykode Therapeutics ASA — Director's Dealing 2021

Sep 20, 2021

1	Details of the closely associated enterprise
a)	Name	Oppenheim AS
2	Details of the person discharging managerial responsibilities
a)	Name	Jan Haudemann-Andersen
b)	Position	Board Member
3	Reason for notification
a)	Position/Status	Company is 100% owned by Karoline Steiro, a closely associated person of Jan Haudemann-Andersen, member of the board of Vaccibody AS.
b)	Initial notification/ Amendment	Initial
4	Details of issuer
a)	Name	Vaccibody AS
b)	LEI	254900UKQHWYZJD22017
5	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Shares in Vaccibody AS (ISIN: NO0010714785)
b)	Nature of the transaction	Sale of shares to closely associated enterprise
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		NOK 71	300,000
d)	Aggregated information	Price	NOK 71
	-Average price,	Volume	300,000
	aggregated volume and total amount	Total amount	NOK 21,300,000
e)	Date of the transaction	20.09.2021
f)	Place of the transaction	MERK – Euronext Growth Oslo